Quarterly report · Q1
8086.TEDINET S100OZ7P
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥127.9bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥494.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥118.0bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥3.0bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥5.5bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥7.3bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥27.6bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.2bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥9.0bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥5.3bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥5.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥13.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.3bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥5.7bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥947.6bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥930.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥874.8bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥730.3bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥730.5bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥217.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥199.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥185.9bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥84.7bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥95.3bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥32.35 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.5 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.24 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥28.66 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥77.42 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 21.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥154m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥855m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | ¥211m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥9.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥9.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥7.1bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥99.3bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥97.7bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥8.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥23.2bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥17.9bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥5.3bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥407m |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥12.2bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥136.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥127.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥8.4bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥9.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥137.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥127.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥9.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥10.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥693m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥153m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥540m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | ¥145m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥8.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥8.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥5.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥92.2bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥90.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥9.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥21.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥16.4bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥5.1bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥587m |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥12.4bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥10.8bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥844m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥126.1bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥117.8bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥8.2bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥10.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥126.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥118.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥11.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0453 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 7762700 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 7762700 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0453 | |
| Cash and deposits | Prior1YearInstant | 95342000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 84657000000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 140285000000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 147785000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 118315000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 122005000000 | JPY |
| Work in process | Prior1YearInstant | 15028000000 | JPY |
| Work in process | CurrentQuarterInstant | 16120000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 42801000000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 46081000000 | JPY |
| Other ca | Prior1YearInstant | 27506000000 | JPY |
| Other ca | CurrentQuarterInstant | 32913000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -1821000000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant | -2763000000 | JPY |
| Current assets | Prior1YearInstant | 437459000000 | JPY |
| Current assets | CurrentQuarterInstant | 446800000000 | JPY |
| Buildings and structures | Prior1YearInstant | 264032000000 | JPY |
| Buildings and structures | CurrentQuarterInstant | 268862000000 | JPY |
| Accumulated depreciation and impairment loss buildings and structures | Prior1YearInstant | -136425000000 | JPY |
| Accumulated depreciation and impairment loss buildings and structures | CurrentQuarterInstant | -140512000000 | JPY |
| Buildings and structures net | Prior1YearInstant | 127606000000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 128349000000 | JPY |
| Machinery equipment and vehicles | Prior1YearInstant | 328271000000 | JPY |
| Machinery equipment and vehicles | CurrentQuarterInstant | 341141000000 | JPY |
| Accumulated depreciation and impairment loss machinery equipment and vehicles | Prior1YearInstant | -244162000000 | JPY |
| Accumulated depreciation and impairment loss machinery equipment and vehicles | CurrentQuarterInstant | -253513000000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 84108000000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 87628000000 | JPY |
| Land | Prior1YearInstant | 51776000000 | JPY |
| Land | CurrentQuarterInstant | 45474000000 | JPY |
| Lease assets ppe | Prior1YearInstant | 31892000000 | JPY |
| Lease assets ppe | CurrentQuarterInstant | 32264000000 | JPY |
| Accumulated depreciation lease assets ppe | Prior1YearInstant | -9233000000 | JPY |
| Accumulated depreciation lease assets ppe | CurrentQuarterInstant | -9903000000 | JPY |
| Lease assets net ppe | Prior1YearInstant | 22659000000 | JPY |
| Lease assets net ppe | CurrentQuarterInstant | 22360000000 | JPY |
| Construction in progress | Prior1YearInstant | 70281000000 | JPY |
| Construction in progress | CurrentQuarterInstant | 80102000000 | JPY |
| Other ppe | Prior1YearInstant | 80978000000 | JPY |
| Other ppe | CurrentQuarterInstant | 84170000000 | JPY |
| Accumulated depreciation and impairment loss other ppe | Prior1YearInstant | -59660000000 | JPY |
| Accumulated depreciation and impairment loss other ppe | CurrentQuarterInstant | -61923000000 | JPY |
| Other net ppe | Prior1YearInstant | 21318000000 | JPY |
| Other net ppe | CurrentQuarterInstant | 22246000000 | JPY |
| Property plant and equipment | Prior1YearInstant | 377752000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |